ArticleJournal of experimental & clinical cancer research : CR2024

Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype.

Valentina Doldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.